Detailed content of our market study


  • Number of pages : ~ 40 pages
  • Format : Digital and PDF versions
  • Last update :
Update Details

Summary and extracts

1 Market Overview

1.1 Definition and presentation

In recent years, the field of diagnostic imaging has experienced exponential growth, becoming a key pillar in health care. According to the World Health Organization (WHO), technological advancement in this field has radically transformed methodologies for the diagnosis and treatment of diseases, providing healthcare professionals with increasingly sophisticated tools for the confirmation, evaluation and monitoring of different clinical conditions. With the global diagnostic imaging market projected to reach $53.344 billion by 2028, up from $38.034 billion in 2022, and a compound annual growth rate(CAGR) of 5.8 percent projected from 2022 to 2028, the importance of this sector is indisputable. In Italy, the market has shown significant growth, with a 30.3% increase in revenue from 2017 to 2021, signaling growing interest and investment in this area.

In parallel with technological development,artificial intelligence (AI) has begun to play a key role in diagnostic imaging, marking one of the most significant advances in the field of Computer Vision (CV). This innovation focuses on the analysis and interpretation of images and videos, and has been successfully applied in radiology for the detection and classification of abnormalities in X-rays, computed tomography (CT) scans, and magnetic resonance imaging (MRI). The use of AI has not only led to more accurate diagnoses but has also improved the efficiency of decision-making, paving the way for faster, more effective and more personalized health care.

The convergence of the rapid development of AI and the evolution of diagnostic imaging sets the stage for a revolution in patient care and treatment, with profound implications for the future of the healthcare industry. This market research aims to explore the current and future dynamics of diagnostic imaging, with a particular focus on the impact of artificial intelligence and growth prospects in the Italian context, in order to understand emerging trends and opportunities for innovation in the field.

1.2 The World Market

According to theWorld Health Organization (***), diagnostic imaging has developed rapidly and plays a central role in health care, supporting the diagnosis and treatment of diseases. Diagnostic imaging services include confirming, evaluating, and documenting the course of many conditions to ultimately identify response to treatment. The global diagnostic imaging market is expected ...

1.3 The Italian Market

As for the Italian market, this has been steadily and sharply increasing in recent years. Companies that perform diagnostic imaging services fall under the category of Ateco Code "**.** - Other health care services."It can be seen that from **** to ****, there has been a **.*% growth in the industry's turnover.

Evolution Turnover ...

1.4 Foreign trade

For the analysis of imports and exports of equipment used to perform medical imaging services, the following HS codes reported from the United Nations database were used. The HSs used are :

****: Equipment based on the use of X-rays or alpha, beta and gamma radiation for medical, surgical, dental or veterinary ...

2 Demand analysis

2.1 Overview of the hospital sector in Italy

In ****, the facilities surveyed are: *** for hospital care, *,*** for outpatient specialty care, *,*** for residential territorial care, *,*** for semiresidential territorial care, *,*** for other territorial care, and *,*** for rehabilitation care (***).


In the following table it is possible, then, to observe further characteristics of the Italian healthcare fabric. Here we have a division ...

2.2 The type of diagnostic imaging services provided and geographic distribution

There are several types of medical imaging that can be requested by patients. The two main types are nuclear medicine and diagnostic radiology. Nuclear medicine refers to the branch of medicine that uses radioactive substances (***) for diagnostic, therapeutic, and biomedical research purposes. While diagnostic radiology uses X-rays, CT, MRI, ultrasound, etc. ...

2.3 The machinery in different regions

In the following section, the number of certain equipment used to make imaging diagnoses will be analyzed. These are:

Echotomograph(***). Computerized Gamma Camera(***) : equipment used in nuclear medicine for scintigraphic imaging; no X-rays are used here Integrated gamma camera CT system(***) : equipment used in nuclear medicine for acquisition of scintigraphic images, ...

2.4 Socio demographic characteristics

There are several drivers that can drive the demand for diagnostic imaging. we can, therefore, find two main categories to keep in mind: demographic characteristics of the Italian population and income characteristics. The age distribution and median age of the Italian population are also important factors to consider in order to ...

3 Market structure

3.1 Market structure and dynamics

To analyze the size of the market, it is useful to dwell on the trend of business activity in the sector of manufacturing irradiation instruments, electromedical and electrotherapeutic equipment. The sector has been trending positively for the last five years taken into analysis, with the exception of the last year available ...

3.2 Value Chain

The following is a simplified value chain of the diagnostic imaging industry:

The market for medical imaging equipment manufacturing in Italy is held by a handful of international players; this is caused by high R&D and manufacturing costs, which raise barriers to market entry and restrain the arrival of new ...

3.3 Companies offering Medical Imaging Services

Clinical testing laboratories, X-ray laboratories, and other imaging centers are a crucial distribution channel for medical imaging products. These centers provide essential diagnostic services, using a wide range of imaging products, such as equipment for radiography, magnetic resonance imaging (***), and ultrasound. There are a total of *,*** facilities in Italy surveyed under ...

3.4 Main actors

4 Supply analysis

4.1 The different types of Equipment

There are many technological modalities of medical imaging, for multiple applications, the main ones of which are listed in the table below:


The following is a non-exhaustive list of the main types of medical imaging equipment:

Conventional and digital radiography Radioscopy / fluoroscopy CT / CAT SCAN Magnetic resonance imaging (***) Functional magnetic ...

4.2 Equipment prices and diagnostic imaging fees

Equipment prices

Prices for major medical imaging equipment can vary widely depending on the brand, the features and modifications made to the equipment, and the customer's needs. However, SNITEM offers a range of prices for high-end equipment:

Installation costs are added to the cost of the equipment. Installation costs between €***,*** and ...

4.3 An obsolete fleet

By ****, there are **,*** obsolete imaging equipment such as MRIs, PET scans, CT scans, angiographs, and mammograms. **% of conventional mammograms are more than ** years old, **% of PET scans are more than * years old, and **% of closed *.* T MRIs are still more than ** years old. A positive sign can be seen among portable ...

4.4 The Future of Artificial Intelligence in Diagnostic Imaging

Artificial intelligence (***), the area that focuses on image and video analysis and interpretation.

Artificial Intelligence at the heart of Diagnostic Imaging

The medical discipline of Diagnostic Imaging has found itself at the center of a scientific and productive fervor. Using AI in Radiology shows remarkable successes in the process of detecting ...

5 Regulations

5.1 Regulation

European regulations

At the European level, new regulations were approved in ****, enforced from **** for medical imaging equipment.

This new regulation:

Strengthens controls on high-risk devices through the establishment of an expert committee to verify the risks of a device before it is placed on the market. Improves transparency in the industry ...

6 Positioning of actors

6.1 Segmentation

  • Gruppo San Donato
  • Synlab Italia SRL
  • Deep Trace Technologies
  • D- EYE
  • General Medical Merate SPA
  • Bracco Imaging SPA
  • AGFA Group

List of charts presented in this market study

  • Global diagnostic imaging market value
  • Evolution Turnover of the Diagnostic Imaging Market
  • Evolution of Turnover and Value of Production Electromedical Equipment in Italy
  • Evolution Imports of Medical Imaging Equipment, by type of technology used
  • Evolution Exports of Medical Imaging Equipment, by Type of Technology Used
Show more Hide

All our studies are available online in PDF format

Take a look at an example of our research on another market!

Do you have a question about this study?   +44 238 097 0676

Latest news

Esaote introduces two new ultrasound systems at Arab Health: the MyLab™A50 and MyLab™A70. - 29/01/2024
  • Company: Esaote, an Italian innovator in the field of medical imaging.
  • Event: Participation in Arab Health from January 29 to February 1, 2024 at the Dubai World Trade Centre, Hall 1 Stand S 1.A30.
  • Product: Launch of two new ultrasound systems, MyLab™A50 and MyLab™A70.
  • Product Features:
    • Designated for compactness, battery operation, mobility and light weight.
    • Offer an enhanced user experience with conventional and touch-enabled options in the control panel.
    • Intuitive design, easy to use and clean.
    • Expected to meet daily and advanced clinical needs, including multiparametric liver analysis, elastography, attenuation imaging, and advanced cardiology applications.
  • Innovations: Implementation of artificial intelligence-based features and advanced imaging technologies for more accurate diagnostic results.
  • Approvals: The MyLab™A50 and MyLab™A70 devices are awaiting 510(k) approval from the FDA and are not available for sale in the United States at the time of this release.
  • About the Company:- Esaote is a leader in the medical imaging industry, specializing in ultrasound, MRI, and diagnostic management software. - At the end of 2023, Esaote has 1,250 employees, with half based in Italy. - It has headquarters in Genoa and Florence, with production and research units in Italy and the Netherlands. - Esaote operates in more than 100 countries.
  • Brand Identity: The launch of the MyLab™ A-series and the new brand identity represent a movement toward Esaote's commitment to improving people's well-being through an approach that combines care and empathy.
Esaote unveils its new brand identity at Worldwide Sales & Marketing Meeting - 25/01/2024
  1. Introducing new brand identity: The Worldwide Sales & Marketing Meeting 2024 event marked the debut of Esaote's new brand identity, which brought together some 400 managers, business partners and stakeholders from 100 different countries.
  2. Objectives of the revamp: The revamp process aims to modernize the logo to express science, innovation, technology and to convey the values of care, empathy and sensitivity. The new logo adopts new colors, essential graphic elements and introduces a new pay-off "Health with Care" aimed at the global market.
  3. Corporate strategy and vision: The change in Esaote's brand identity is intended to reflect the company's vision and mission, aligning with its core values and corporate strategy of making complexity simple.
  4. Importance of branding and positioning: The decision to retain the naming "esaote" and the introduction of the English pay-off demonstrate the company's intent to enhance its roots while speaking to an international audience.
  5. Number of employees and market presence: At the end of 2023, the Esaote Group had 1,250 employees, half of whom are located in Italy. The company has headquarters in Genoa and Florence, with production and research units in Italy and the Netherlands, and is present in more than 100 countries around the world.
  6. Products and target market: Esaote is a leader in medical imaging, specifically in ultrasound, MRI, and diagnostic process management software.
  7. New web platform: The company launched a new website ( with an information architecture that facilitates access to content and places an emphasis on people and relationships in the context of health.
Bracco Imaging Receives Favorable CHMP Opinion for Gadopiclenol - 13/10/2023

Bracco Imaging has received a favorable CHMP opinion for Gadopiclenol as an MRI injectable solution:

  • The solution is indicated for adult and pediatric patients aged 2 years and older for MRI of the central nervous system and various body organs.
  • Gadopiclenol was approved by the U.S. Food and Drug Administration (FDA) in September 2022.
  • it is a very stable macrocyclic contrast agent with the highest relaxivity among all other GBCAs on the market, and its approved dose is half that of other macrocyclic GBCAs for similar indications.
  • The CHMP opinion is based on the results of two prospective clinical trials (PICTURE and PROMISE), conducted in more than 500 adult patients.
  • These studies compared the safety and efficacy of 0.05 mmol/kg gadopiclenol versus 0.1 mmol/kg gadobutrol in different anatomic regions.
  • Gadopiclenol offers two- to three-fold higher relaxivity than other available GBCAs and can be used with any MRI scanner.
  • Its macrocyclic structure confers high stability and allows diagnostic efficiency at a lower dose than other GBCAs, reducing the risk of gadolinium retention in body tissues and the environment.

Companies quoted in this study

This study contains a complete overview of the companies in the market, with the latest figures and news for each company. :

Gruppo San Donato
Synlab Italia SRL
Deep Trace Technologies
General Medical Merate SPA
Bracco Imaging SPA
AGFA Group

Choosing this study means :

Access to more than 35 hours of work

Our studies are the result of over 35 hours of research and analysis. Using our studies allows you to devote more time and added value to your projects.

Benefit from 6 years' experience and over 1,500 industry reports already produced

Our expertise enables us to produce comprehensive studies in all sectors, including niche and emerging markets.

Our know-how and methodology enable us to produce reports that offer unique value for money.

Access to several thousand articles and paid-for data

Businesscoot has access to all the paid economic press as well as exclusive databases to carry out its market research (over 30,000 articles and private sources).

To enhance our research, our analysts also use web indicators (semrush, trends, etc.) to identify market trends and company strategies. (Consult our paying sources)

Guaranteed support after your purchase

A team dedicated to after-sales service, to guarantee you a high level of satisfaction. +44 238 097 0676

A digital format designed for our users

Not only do you have access to a PDF, but also to a digital version designed for our customers. This version gives you access to sources, data in Excel format and graphics. The content of the study can therefore be easily retrieved and adapted for your specific needs.

Our offers :

the medical imaging market | Italy

99 €
  • What are the figures on the size and growth of the market?
  • What is driving the growth of the market and its evolution?
  • What is the positioning of companies in the value chain?
  • Data from several dozen databases

5 reports pack (-15%) IT Italy

75.6 € / study
378 € instead of 445 € -15%
  • 5 reports at €75.6 excluding VAT per study to choose from our Italian catalogue for 12 months
  • Save 15% on additional studies purchased
  • Choose to be refunded any unused credit at the end of the 12-month period (duration of the pack)

See the terms and conditions of the pack and the refund of unused credit.


Our customer references

They have consulted our studies Discover the opinions (+500)

Malcolm Vincent
Linkedin logo

Malcolm Vincent

Astoria Finance

Gregoire de Castelnau
Linkedin logo

Gregoire de Castelnau

Stags Participations

Timothé Huignard
Linkedin logo

Timothé Huignard


Paul-Alexis Kebabtchieff
Linkedin logo

Paul-Alexis Kebabtchieff


Aymeric Granet
Linkedin logo

Aymeric Granet

Publicis Consultant

interviews & case studies All interviews and case studies (45)

La pépite Interview

BFM Business

Paul-Alexis Kebabtchieff

Boston Consulting Group

Marie Guibart

Kea Partners

Elaine, Durand

Crédit Agricole, Information & Veille

Philippe Dilasser

Initiative & Finance

Anne Baudry


Amaury Wernert

Kroll (Duff & Phelps)

Smart Leaders Interview


Do you have a question ?
Our team is at your disposal at   +44 238 097 0676